GC813
GC813 is a MERS-CoV 3CL protease (3CLpro) and MERS-CoV main protease (Mpro) inhibitor. GC813 can be used for the research of middle east respiratory syndrome.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2170616-59-6
- 分子式: C22H31ClN3NaO8S
- 分子量:556.00
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
GC813 (3 mM; overnight) can bind to purified MERS-CoV 3CLpro, form a covalent adduct with the active site Cys148, and interact with the S1, S2 and S4 subsites of the enzyme[1].
GC813 (48 h) potently inhibits MERS-CoV replication in Vero81 cells with an EC50 of 0.5 µM[1].
GC813 binds to MERS-CoV Mpro with a binding energy of -8.1 kcal/mol via multiple hydrogen bonds and hydrophobic interactions[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 2170616-59-6
-
分子量 556.00
-
分子式 C22H31ClN3NaO8S
-
SMILES
O=C(NCC1)[C@@H]1C[C@@H](C(O)S(=O)(O[Na])=O)NC([C@H](CC(C)C)NC(OCCC2=CC(Cl)=CC=C2)=O)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Galasiti Kankanamalage AC, et al. Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element. Eur J Med Chem. 2018 Apr 25;150:334-346. [Content Brief]
[2]. Gurung AB, et al. In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors. Saudi J Biol Sci. 2020;27(10):2674-2682. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
GC813 関連分類
HY-183956 関連分類
Powered by Bioz